We are live on ! Find out more
IMVT icon

Immunovant
IMVT

110 hedge funds and large institutions have $407M invested in Immunovant in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

538% more call options, than puts

Call options by funds: $56.4M | Put options by funds: $8.84M

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

1.93% less ownership

Funds ownership: 41.29% → 39.35% (-1.9%)

8% less funds holding

Funds holding: 120 → 110 (-10)

32% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 31

38% less capital invested

Capital invested by funds: $653M → $407M (-$246M)

Holders
110
Holders Change
-10
Holders Change %
-8.33%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
45
Reduced
31
Closed
31
Calls
$56.4M
Puts
$8.84M
Net Calls
+$47.6M
Net Calls Change
+$39M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$39.8M
2
AGM
Alpine Global Management
New York
+$12.6M
3
EAM
Eventide Asset Management
Massachusetts
+$12.5M
4
Morgan Stanley
Morgan Stanley
New York
+$11M
5
State Street
State Street
Massachusetts
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$102M
2
Goldman Sachs
Goldman Sachs
New York
-$11.7M
3
BlackRock
BlackRock
New York
-$8.13M
4
CS
Candriam SCA
Luxembourg
-$8.06M
5
OM
Opaleye Management
Massachusetts
-$7.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
26
Frazier Management
Washington
$2.69M -$3.55M -254,000 -50%
American Century Companies
27
American Century Companies
Missouri
$2.65M +$20K +1,431 +0.6%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$2.64M +$2.9M +207,373 +489%
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
29
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$2.49M +$3.29M +235,600 New
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.19M +$155K +11,091 +6%
Goldman Sachs
31
Goldman Sachs
New York
$2.17M -$11.7M -840,647 -80%
IC
32
Ikarian Capital
Texas
$1.96M +$2.59M +185,500 New
Deutsche Bank
33
Deutsche Bank
Germany
$1.95M +$342K +24,511 +15%
HF
34
HRT Financial
New York
$1.89M +$2.5M +178,844 New
Citadel Advisors
35
Citadel Advisors
Florida
$1.85M -$5.37M -384,929 -69%
ECM
36
ExodusPoint Capital Management
New York
$1.75M +$2.31M +165,417 New
MWNA
37
Marshall Wace North America
New York
$1.73M +$2.29M +163,956 New
JF
38
Jump Financial
Illinois
$1.47M +$1.63M +116,471 +516%
PP
39
PDT Partners
New York
$1.43M +$1.89M +135,700 New
Bank of America
40
Bank of America
North Carolina
$1.43M +$146K +10,428 +8%
AA
41
ALPS Advisors
Colorado
$1.36M -$673K -48,198 -27%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$1.3M -$364K -26,082 -18%
Jane Street
43
Jane Street
New York
$1.24M +$1.45M +104,172 +769%
EP
44
Eversept Partners
New York
$1.16M -$1.68M -120,000 -52%
PPA
45
Parametric Portfolio Associates
Washington
$1.13M +$1.19M +85,241 +400%
DMK
46
David M. Knott
$1.03M +$882K +63,194 +185%
AllianceBernstein
47
AllianceBernstein
Tennessee
$978K +$824K +59,000 +176%
Swiss National Bank
48
Swiss National Bank
Switzerland
$799K -$26.5K -1,900 -2%
ICM
49
Ionic Capital Management
New York
$740K +$977K +70,000 New
CS
50
Credit Suisse
Switzerland
$724K +$283K +20,267 +42%
1
2
3 4 5

IMVT Hedge Fund Activity: Q2 2021 in Review

110 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q2 2021, worth a combined $407M — down 38% from $653M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of IMVT and 21 opened new positions — a net loss of 10 holders — while 31 trimmed existing stakes and 45 added.

The largest buyer was Woodline Partners, adding an estimated $39.8M. The largest seller was RTW Investments, exiting entirely with an estimated $102M sold.

  • 110 institutional investors held Immunovant (IMVT) as of Q2 2021, down from 120 in Q1 2021.
  • Funds reported $407M of Immunovant stock for Q2 2021, down 38% quarter-over-quarter.
  • 21 funds opened new Immunovant positions in Q2 2021 and 31 closed out, a net change of -10 holders.
  • The largest Immunovant buyer in Q2 2021 was Woodline Partners, an estimated $39.8M added.
  • The largest Immunovant seller in Q2 2021 was RTW Investments, an estimated $102M sold.

Based on aggregated 13F filings for Q2 2021.